Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $6.8300 (-5.01%) ($6.8300 - $6.8300) on Thu. Oct. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.33% (three month average) | RSI | 40 | Latest Price | $6.8300(-5.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(77%) XBI(76%) IBB(65%) ARKK(62%) IBUY(61%) | Factors Impacting EDIT price | EDIT will decline at least -1.665% in a week (0% probabilities). TBT(-21%) VXX(-16%) UUP(-13%) VIXM(-12%) EDOC(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.665% (StdDev 3.33%) | Hourly BBV | -2.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.85(-185.65%) | Resistance Level | $7.39 | 5 Day Moving Average | $7.1(-3.8%) | 10 Day Moving Average | $7.18(-4.87%) | 20 Day Moving Average | $7.39(-7.58%) | To recent high | -26.4% | To recent low | 0% | Market Cap | $424m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |